Skip to content

A study to evaluate the dose-response efficacy of body fat reduction by continuous ingestion of test food. (SWE-2023-07-HCRINK)

A study to evaluate the dose-response efficacy of body fat reduction by continuous ingestion of test food. (SWE-2023-07-HCRINK) - A study to evaluate the dose-response efficacy of body fat reduction by continuous ingestion of test food.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000051748
Enrollment
200
Registered
2023-07-30
Start date
2023-07-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intake of the high-dose test foods for 12 weeks. Intake of the medium-dose test foods for 12 weeks. Intake of the low-dose test foods for 12 weeks. Intake of the control foods for 12 weeks.

Sponsors

Suntory Wellness Limited
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Males and females who are 20 -< years old < 65 from the time of IC acquisition to the end of the study. (2) Subjects who can come to the designated premises on the date of the scheduled visit. (3) Subjects who can understand the purpose and content of this study and agree in writing to participate in this study.

Exclusion criteria

Exclusion criteria: (1) Subjects who have regular hard exercise. (2) Heavy drinker of alcohol and heavy smoker (3) Subjects who use of products affecting the data of this study, such as food for specified health use, and food with function claims. (4) Subjects who continuously take medicines. (5) Subjects who are participating in other study or planning to participate or participated within the past 4 weeks. (6) Subjects who are: a) heart, liver, or kidney disease (including complications of other diseases) b) undergoing treatment for or have a history of cardiovascular disease c) diabetes d) allergic to test foods e) undergoing treatment for or have a history of serious diseases such as cancer or tuberculosis f) having history of comorbidities in the gastrointestinal tract (excluding a history of cecum) (7) Others who are judged inappropriate for participant by the investigator

Design outcomes

Primary

MeasureTime frame
Abdominal total fat area

Countries

Japan

Contacts

Public ContactMui Iida

Suntory Wellness Limited Institute for Science of Life

Mui_Iida@suntory.co.jp050-1734-9361

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026